NCT00860704

Goal Directed Fluid Therapy

Intraoperative Goal Directed Fluid Therapy in Lean and Obese Patients

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 90 (actual)
• Sponsor: Medical University of Vienna · Academic / Other
• Sex: Female
• Age: 18 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

Intraoperative fluid demand will be monitored by Esophageal Doppler in lean and obese patients.

Detailed description

To our knowledge no data are available on the effect of goal-directed fluid therapy on hemodynamics in lean patients and obese patients, respectively. Consequently, we want to compare lean patients (BMI \<25) vs. obese patients (BMI \>25) in regard of their respective needs for intraoperative fluid therapy, and the impact of the goal-directed fluid regimen on tissue oxygenation.

Conditions

• Goal Directed Fluid Therapy

Interventions

Type	Name	Description
DRUG	fluidotherapy with ringer-lactate	a bolus of 250ml ringer-lactate is administered, if there is fluid demand monitored by the Esophageal Doppler

Timeline

• Start date: 2007-11-01
• Primary completion: 2012-12-01
• Completion: 2012-12-01
• First posted: 2009-03-12
• Last updated: 2018-10-18

Locations

1 site across 1 country: Austria